pioglitazone has been researched along with Osteomyelitis in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Osteomyelitis: INFLAMMATION of the bone as a result of infection. It may be caused by a variety of infectious agents, especially pyogenic (PUS - producing) BACTERIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Osteomyelitis is an acute or chronic inflammatory bone disease with a high disability rate." | 1.72 | PPAR-γ agonist pioglitazone alleviates inflammatory response induced by lipopolysaccharides in osteoblast cells. ( Guo, QF; Huang, K; Lin, BY; Liu, YY; Ma, GP; Wang, LJ; Yu, HJ; Yu, M, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, HJ | 1 |
| Wang, LJ | 1 |
| Huang, K | 1 |
| Guo, QF | 1 |
| Lin, BY | 1 |
| Liu, YY | 1 |
| Yu, M | 1 |
| Ma, GP | 1 |
1 other study available for pioglitazone and Osteomyelitis
| Article | Year |
|---|---|
PPAR-γ agonist pioglitazone alleviates inflammatory response induced by lipopolysaccharides in osteoblast cells.
Topics: Animals; Anti-Inflammatory Agents; Cytokines; Hypoglycemic Agents; Interleukin-6; Lipopolysaccharide | 2022 |